We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+8.74%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$136B
AUM Growth
+$19.8B
Cap. Flow
+$10.6B
Cap. Flow %
7.76%
Top 10 Hldgs %
11.1%
Holding
5,079
New
591
Increased
1,620
Reduced
1,625
Closed
731

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$964M
2
AAPL icon
Apple
AAPL
+$606M
3
WDAY icon
Workday
WDAY
+$520M
4
PLTR icon
Palantir
PLTR
+$514M
5
SPOT icon
Spotify
SPOT
+$431M

Sector Composition

Rank Sector Weight
1 Technology 13.54%
2 Consumer Discretionary 8.87%
3 Healthcare 8.21%
4 Financials 5.68%
5 Industrials 4.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LANV.WS
4201
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
$1K ﹤0.01%
25,000
SVMHW
4202
DELISTED
SRIVARU Holding Limited Warrant
SVMHW
$978 ﹤0.01%
115,000
PRENW
4203
Prenetics Global Ltd Warrant
PRENW
$91.6K
$815 ﹤0.01%
104,515
XBPEW
4204
XBP Europe Holdings Warrant
XBPEW
$789 ﹤0.01%
19,714
GGROW
4205
Gogoro Inc Warrant
GGROW
$133K
$757 ﹤0.01%
44,527
GSMGW
4206
DELISTED
Cheer Holding, Inc. Warrant expiring 2/13/2025
GSMGW
$498 ﹤0.01%
498,473
BENFW icon
4207
Beneficient Warrant
BENFW
$152K
$150 ﹤0.01%
19,500
ABCB icon
4208
Ameris Bancorp
ABCB
$5.77B
-22,692
Closed -$1.42M
ABCL icon
4209
AbCellera Biologics
ABCL
$3.44B
-420,240
Closed -$1.09M
ABM icon
4210
ABM Industries
ABM
$2.75B
-9,484
Closed -$500K
ABSI icon
4211
Absci
ABSI
$1.52B
-245,770
Closed -$939K
ACB
4212
Aurora Cannabis
ACB
$249M
-13,443
Closed -$79K
ACGL icon
4213
Arch Capital
ACGL
$34.5B
-158,405
Closed -$17.7M
ACHR icon
4214
PUT
Archer Aviation
ACHR
$4.67B
-50,000
Closed -$152K
ACLX
4215
DELISTED
Arcellx
ACLX
-6,305
Closed -$527K
ADCT icon
4216
ADC Therapeutics
ADCT
$123M
-284,243
Closed -$895K
AEE icon
4217
Ameren
AEE
$29.7B
-3,374
Closed -$295K
AFG icon
4218
American Financial Group
AFG
$12B
-4,442
Closed -$598K
AFL icon
4219
PUT
Aflac
AFL
$59.3B
-4,800
Closed -$537K
AGNC icon
4220
AGNC Investment
AGNC
$13B
-150,555
Closed -$1.47M
AGYS icon
4221
Agilysys
AGYS
$3.21B
-27,064
Closed -$2.95M
AHCO icon
4222
CALL
AdaptHealth
AHCO
$751M
-19,400
Closed -$218K
AHCO icon
4223
PUT
AdaptHealth
AHCO
$751M
-15,600
Closed -$175K
AHRT
4224
AH Realty Trust
AHRT
$502M
-49,433
Closed -$535K
AIG icon
4225
CALL
American International
AIG
$40.5B
-18,100
Closed -$1.33M

Similar funds

David Shaw's Q4 2024 Portfolio in Review

As of Q4 2024, David Shaw held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

David Shaw deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.

  • David Shaw's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
  • David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
  • David Shaw's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
  • David Shaw fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
  • David Shaw's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
  • David Shaw opened 591 new positions and closed 731 in Q4 2024.
  • David Shaw's portfolio value rose 17% quarter-over-quarter to $136B.

Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.